Emerging roles for the FCRL family members in lymphocyte biology and disease

Current Topics in Microbiology and Immunology

Volumn 382, Issue , 2014, Pages 29-50

  Li, F J ^a   Won, W J ^a   Becker Jr , E J ^b   Easlick, J L ^a   Tabengwa, E M ^a   Li, R ^a   Shakhmatov, M ^a   Honjo, K ^a   Burrows, P D ^b,d,e   Davis, R S ^a,b,c,e  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; FCRL PROTEIN; HLA DR ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG; FC RECEPTOR; FC RECEPTOR LIKE PROTEIN;

ADAPTIVE IMMUNITY; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CHRONIC LYMPHATIC LEUKEMIA; FCRL GENE; FCRL1 GENE; FCRL2 GENE; FCRL3 GENE; FCRL4 GENE; FCRL5 GENE; FCRL6 GENE; FCRLA GENE; FCRLB GENE; FOLLICULAR LYMPHOMA; GENE; GENE EXPRESSION REGULATION; GENE LOCATION; GRAVES DISEASE; HUMAN; IMMUNOBIOLOGY; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IN VIVO STUDY; INNATE IMMUNITY; LARGE CELL LYMPHOMA; LIGAND BINDING; LYMPHOCYTE; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION; ARTICLE; AUTOIMMUNE DISEASE; DISEASE ACTIVITY; IMMUNE RESPONSE; MOLECULAR PATHOLOGY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANIMALS; B-LYMPHOCYTES; HUMANS; LIGANDS; RECEPTORS, FC; SIGNAL TRANSDUCTION;

EID: 84958553891     PISSN: 0070217X     EISSN: 21969965     Source Type: Book Series    
DOI: 10.1007/978-3-319-07911-0_2     Document Type: Review

References (91)

1. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511
2. Arthos J, Cicala C, Martinelli E, Macleod K, Van Ryk D, Wei D et al (2008) HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol 9:301-309
3. Bajpai UD, Swainson LA, Mold JE, Graf JD, Imboden JB, McCune JM (2012) A functional variant in FCRL3 is associated with higher Fc receptor-like 3 expression on T cell subsets and rheumatoid arthritis disease activity. Arthritis Rheum 64:2451-2459
4. Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S et al (2009) Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 113:3716-3725
5. Campbell JA, Davis RS, Lilly LM, Fremont DH, French AR, Carayannopoulos LN (2010) Cutting edge: FcR-like 5 on innate B cells is targeted by a poxvirus MHC class I-like immunoevasin. J Immunol 185:28-32
6. Campbell JA, Trossman DS, Yokoyama WM, Carayannopoulos LN (2007) Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D. J Exp Med 204:1311-1317
7. Capolunghi F, Cascioli S, Giorda E, Rosado MM, Plebani A, Auriti C et al (2008) CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J Immunol 180:800-808
8. Cerutti A, Cols M, Puga I (2013) Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol 13:118-132
9. Chan VW, Meng F, Soriano P, DeFranco AL, Lowell CA (1997) Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7:69-81
10. Charles ED, Green RM, Marukian S, Talal AH, Lake-Bakaar GV, Jacobson IM et al (2008) Clonal expansion of immunoglobulin M + CD27 + B cells in HCV-associated mixed cryoglobulinemia. Blood 111:1344-1356
11. Chikaev NA, Bykova EA, Najakshin AM, Mechetina LV, Volkova OY, Peklo MM et al (2005) Cloning and characterization of the human FCRL2 gene. Genomics 85:264-272
12. Chistiakov DA, Chistiakov AP (2007) Is FCRL3 a new general autoimmunity gene? Hum Immunol 68:375-383
13. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94:1840-1847
14. Davis RS, Dennis G Jr, Odom MR, Gibson AW, Kimberly RP, Burrows PD et al (2002a) Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family. Immunol Rev 190:123-136
15. Davis RS, Li H, Chen CC, Wang YH, Cooper MD, Burrows PD (2002b) Definition of an Fc receptor-related gene (FcRX) expressed in human and mouse B cells. Int Immunol 14:1075-1083
16. Davis RS, Stephan RP, Chen CC, Dennis G Jr, Cooper MD (2004) Differential B cell expression of mouse Fc receptor homologs. Int Immunol 16:1343-1353
17. Davis RS, Wang YH, Kubagawa H, Cooper MD (2001) Identification of a family of Fc receptor homologs with preferential B cell expression. Proc Natl Acad Sci USA 98:9772-9777
18. Dement-Brown J, Newton CS, Ise T, Damdinsuren B, Nagata S, Tolnay M (2012) Fc receptorlike 5 promotes B cell proliferation and drives the development of cells displaying switched isotypes. J Leukoc Biol 91:59-67
19. Du X, Nagata S, Ise T, Stetler-Stevenson M, Pastan I (2008) FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins. Blood 111:338-343
20. Ehrhardt GR, Cooper MD (2011) Immunoregulatory roles for fc receptor-like molecules. Curr Top Microbiol Immunol 350:89-104
21. Ehrhardt GR, Davis RS, Hsu JT, Leu CM, Ehrhardt A, Cooper MD (2003) The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc Natl Acad Sci U S A 100:13489-13494
22. Ehrhardt GR, Hijikata A, Kitamura H, Ohara O, Wang JY, Cooper MD (2008) Discriminating gene expression profiles of memory B cell subpopulations. J Exp Med 205:1807-1817
23. Ehrhardt GR, Hsu JT, Gartland L, Leu CM, Zhang S, Davis RS et al (2005) Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J Exp Med 202:783-791
24. Elkins K, Zheng B, Go M, Slaga D, Du C, Scales SJ et al (2012) FcRL5 as a target of antibodydrug conjugates for the treatment of multiple myeloma. Mol Cancer Ther 11:2222-2232
25. Facchetti F, Cella M, Festa S, Fremont DH, Colonna M (2002) An unusual Fc receptor-related protein expressed in human centroblasts. Proc Natl Acad Sci USA 99:3776-3781
26. Falini B, Agostinelli C, Bigerna B, Pucciarini A, Pacini R, Tabarrini A et al (2012) IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas. Histopathology 61:930-941
27. Falini B, Tiacci E, Pucciarini A, Bigerna B, Kurth J, Hatzivassiliou G et al (2003) Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). Blood 102:3684-3692
28. Forconi F, Sahota SS, Raspadori D, Mockridge CI, Lauria F, Stevenson FK (2001) Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing. Blood 98:1174-1181
29. Franco A, Damdinsuren B, Ise T, Dement-Brown J, Li H, Nagata S et al (2013) Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptors. J Immunol 190:5739-5746
30. Gibson AW, Li FJ, Wu JM, Edberg JC, Su KH, Cafardi J et al (2009) The FCRL3-169CT promoter single-nucleotide polymorphism, which is associated with systemic lupus erythematosus in a Japanese population, predicts expression of receptor protein on CD19 + B cells. Arthritis Rheum 60:3510-3512
31. Guselnikov SV, Ershova SA, Mechetina LV, Najakshin AM, Volkova OY, Alabyev BY et al (2002) A family of highly diverse human and mouse genes structurally links leukocyte FcR, gp42 and PECAM-1. Immunogenetics 54:87-95
32. Haga CL, Ehrhardt GR, Boohaker RJ, Davis RS, Cooper MD (2007) Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment. Proc Natl Acad Sci U S A 104:9770-9775
33. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848-1854
34. Hatzivassiliou G, Miller I, Takizawa J, Palanisamy N, Rao PH, Iida S et al (2001) IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 14:277-289
35. Imboden JB, Eriksson EC, McCutcheon M, Reynolds CW, Seaman WE (1989) Identification and characterization of a cell-surface molecule that is selectively induced on rat lymphokineactivated killer cells. J Immunol 143:3100-3103
36. Inozume T, Matsuzaki Y, Kurihara S, Fujita T, Yamamoto A, Aburatani H et al (2005) Novel melanoma antigen, FCRL/FREB, identified by cDNA profile comparison using DNA chip are immunogenic in multiple melanoma patients. Int J Cancer 114:283-290
37. Ise T, Maeda H, Santora K, Xiang L, Kreitman RJ, Pastan I et al (2005) Immunoglobulin superfamily receptor translocation associated 2 protein on lymphoma cell lines and hairy cell leukemia cells detected by novel monoclonal antibodies. Clin Cancer Res 11:87-96
38. Ise T, Nagata S, Kreitman RJ, Wilson WH, Wayne AS, Stetler-Stevenson M et al (2007) Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma. Leukemia 21:169-174
39. Jackson TA, Haga CL, Ehrhardt GR, Davis RS, Cooper MD (2010) FcR-Like 2 Inhibition of B Cell Receptor-Mediated Activation of B Cells. J Immunol 185:7405-7412
40. Jelicic K, Cimbro R, Nawaz F, Huang DW, Zheng X, Yang J et al (2013) The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-beta1 production and FcRL4 expression. Nat Immunol 14(12):1256-1265
41. Kardava L, Moir S, Wang W, Ho J, Buckner CM, Posada JG et al (2011) Attenuation of HIVassociated human B cell exhaustion by siRNA downregulation of inhibitory receptors. J Clin Invest 121:2614-2624
42. Kehrl JH, Thevenin C, Rieckmann P, Fauci AS (1991) Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. J Immunol 146:4016-4023
43. Kochi Y, Myouzen K, Yamada R, Suzuki A, Kurosaki T, Nakamura Y et al (2009) FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. J Immunol 183:5502-5510
44. Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, Sawada T et al (2005) A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 37:478-485
45. Kulemzin SV, Zamoshnikova AY, Yurchenko MY, Vitak NY, Najakshin AM, Fayngerts SA et al (2011) FCRL6 receptor: expression and associated proteins. Immunol Lett 134:174-182
46. Leu CM, Davis RS, Gartland LA, Fine WD, Cooper MD (2005) FcRH1: an activation coreceptor on human B cells. Blood 105:1121-1126
47. Li FJ, Ding S, Pan J, Shakhmatov MA, Kashentseva E, Wu J et al (2008) FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia. Blood 112:179-187
48. Li FJ, Schreeder DM, Li R, Wu J, Davis RS (2013) FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiation. Eur J Immunol 43:2980-2992
49. Maehlen MT, Nordang GB, Syversen SW, van der Heijde DM, Kvien TK, Uhlig T et al (2011) FCRL3 -169C/C genotype is associated with anti-citrullinated protein antibody-positive rheumatoid arthritis and with radiographic progression. J Rheumatol 38:2329-2335
50. Maltais LJ, Lovering RC, Taranin AV, Colonna M, Ravetch JV, Dalla-Favera R et al (2006) New nomenclature for Fc receptor-like molecules. Nat Immunol 7:431-432
51. Martin F, Kearney JF (2000) B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol Rev 175:70-79
52. Masir N, Jones M, Pozzobon M, Marafioti T, Volkova OY, Mechetina LV et al (2004) Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells. Br J Haematol 127:335-343
53. Masuda K, Davis RS, Maruyama T, Zhang J, He T, Cooper MD et al (2005) FcRY, an Fc receptor related gene differentially expressed during B lymphocyte development and activation. Gene 363:32-40
54. Masuda K, Mori H, Ohara O, Nakayama M, Wang JY, Burrows PD (2010) Defining the immunological phenotype of Fc receptor-like B (FCRLB) deficient mice: confounding role of the inhibitory FcgammaRIIb. Cell Immunol 266:24-31
55. Mechetina LV, Najakshin AM, Volkova OY, Guselnikov SV, Faizulin RZ, Alabyev BY et al (2002) FCRL, a novel member of the leukocyte Fc receptor family possesses unique structural features. Eur J Immunol 32:87-96
56. Miller I, Hatzivassiliou G, Cattoretti G, Mendelsohn C, Dalla-Favera R (2002) IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells. Blood 99:2662-2669
57. Mohan J, Dement-Brown J, Maier S, Ise T, Kempkes B, Tolnay M (2006) Epstein-Barr virus nuclear antigen 2 induces FcRH5 expression through CBF1. Blood 107:4433-4439
58. Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, O'Shea MA et al (2008) Evidence for HIVassociated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 205:1797-1805
59. Nagata S, Ise T, Pastan I (2009) Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells. J Immunol 182:7518-7526
60. Nakayama Y, Weissman SM, Bothwell AL (2001) BXMAS1 identifies a cluster of homologous genes differentially expressed in B cells. Biochem Biophys Res Commun 285:830-837
61. Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T (2001) PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci U S A 98:13866-13871
62. Polson AG, Zheng B, Elkins K, Chang W, Du C, Dowd P et al (2006) Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia. Int Immunol 18:1363-1373
63. Pritchard NR, Cutler AJ, Uribe S, Chadban SJ, Morley BJ, Smith KG (2000) Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcgammaRII. Curr Biol 10:227-230
64. Rakhmanov M, Keller B, Gutenberger S, Foerster C, Hoenig M, Driessen G et al (2009) Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci U S A 106:13451-13456
65. Rassenti LZ, Jain S, Keating MJ, Wierda WG, Grever MR, Byrd JC et al (2008) Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood 112:1923-1930
66. Reshetnikova ES, Mechetina LV, Volkova OY, Guselnikov SV, Chikaev NA, Kovesdi D et al (2012) Differential expression of FCRLA in naive and activated mouse B cells. Cell Immunol 272:182-192
67. Rui L, Healy JI, Blasioli J, Goodnow CC (2006) ERK signaling is a molecular switch integrating opposing inputs from B cell receptor and T cell cytokines to control TLR4-driven plasma cell differentiation. J Immunol 177:5337-5346
68. Rui L, Vinuesa CG, Blasioli J, Goodnow CC (2003) Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nat Immunol 4:594-600
69. Santiago T, Kulemzin SV, Reshetnikova ES, Chikaev NA, Volkova OY, Mechetina LV et al (2011) FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA. Int Immunol 23:43-53
70. Schreeder DM, Cannon JP, Wu J, Li R, Shakhmatov MA, Davis RS (2010) Cutting edge: FcRlike 6 is an MHC class II receptor. J Immunol 185:23-27
71. Schreeder DM, Pan J, Li FJ, Vivier E, Davis RS (2008) FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia. Eur J Immunol 38:3159-3166
72. Seaman WE, Niemi EC, Stark MR, Goldfien RD, Pollock AS, Imboden JB (1991) Molecular cloning of gp42, a cell-surface molecule that is selectively induced on rat natural killer cells by interleukin 2: glycolipid membrane anchoring and capacity for transmembrane signaling. J Exp Med 173:251-260
73. Shultz LD, Schweitzer PA, Rajan TV, Yi T, Ihle JN, Matthews RJ et al (1993) Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73:1445-1454
74. Sohn HW, Krueger PD, Davis RS, Pierce SK (2011) FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling. Blood 118:6332-6341
75. Swainson LA, Mold JE, Bajpai UD, McCune JM (2010) Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1. J Immunol 184:3639-3647
76. Weiss GE, Crompton PD, Li S, Walsh LA, Moir S, Traore B et al (2009) Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol 183:2176-2182
77. Weller S, Braun MC, Tan BK, Rosenwald A, Cordier C, Conley ME et al (2004) Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104:3647-3654
78. Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, Kalia V et al (2007) Molecular signature of CD8 + T cell exhaustion during chronic viral infection. Immunity 27:670-684
79. Wilson TJ, Colonna M (2005) A new Fc receptor homolog, FREB2, found in germinal center B cells. Genes Immun 6:341-346
80. Wilson TJ, Fuchs A, Colonna M (2012) Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG. J Immunol 188:4741-4745
81. Wilson TJ, Gilfillan S, Colonna M (2010) Fc receptor-like A associates with intracellular IgG and IgM but is dispensable for antigen-specific immune responses. J Immunol 185:2960-2967
82. Wilson TJ, Presti RM, Tassi I, Overton ET, Cella M, Colonna M (2007) FcRL6, a new ITIMbearing receptor on cytolytic cells, is broadly expressed by lymphocytes following HIV-1 infection. Blood 109:3786-3793
83. Won WJ, Foote JB, Odom MR, Pan J, Kearney JF, Davis RS (2006) Fc receptor homolog 3 is a novel immunoregulatory marker of marginal zone and B1 B cells. J Immunol 177:6815-6823
84. Xiu Y, Nakamura K, Abe M, Li N, Wen XS, Jiang Y et al (2002) Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses. J Immunol 169:4340-4346
85. Xu MJ, Zhao R, Cao H, Zhao ZJ (2002) SPAP2, an Ig family receptor containing both ITIMs and ITAMs. Biochem Biophys Res Commun 293:1037-1046
86. Xu MJ, Zhao R, Zhao ZJ (2001) Molecular cloning and characterization of SPAP1, an inhibitory receptor. Biochem Biophys Res Commun 280:768-775
87. Yang Y, Su X, Zhang K, Zhou R (2013) The Fc receptor-like 3 gene polymorphisms and susceptibility to autoimmune diseases: an updated meta-analysis. Autoimmunity 46:547-558
88. Yasuda T, Kometani K, Takahashi N, Imai Y, Aiba Y, and Kurosaki T (2011) ERKs induce expression of the transcriptional repressor Blimp-1 and subsequent plasma cell differentiation. Sci Signal 4:ra25
89. Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD et al (1998) Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188:2205-2213
90. Zhao SX, Liu W, Zhan M, Song ZY, Yang SY, Xue LQ et al (2013) A refined study of FCRL genes from a genome-wide association study for Graves' disease. PLoS ONE 8:e57758
91. Zhu Z, Li R, Li H, Zhou T, Davis RS (2013) FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling. Proc Natl Acad Sci U S A 110:E1282-E1290